This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Esbatech, an Alcon Biomedical Research Unit LLC, Sucampo Ag. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Saint Cergue, CH (2014)
- St-Cergue, CH (2018)
Company Filing History:
Years Active: 2014-2018
Title: The Innovations of Michael Möller: Pioneering Pharmaceutical Formulations
Introduction
Michael Möller, hailing from St-Cergue, Switzerland, is an accomplished inventor with a remarkable portfolio that boasts three patents. His contributions to the field of pharmaceuticals, particularly in the development of sustained-release injectable formulations, have the potential to revolutionize how proteins are administered in medical treatments.
Latest Patents
Among Michael Möller's most significant inventions are his latest patents concerning protein sustained-release injectable formulations. These innovations focus on providing sustained-release pharmaceutical formulations specifically for administering proteins to the eye. The formulations comprise single-chain antibodies combined with hydrophobic polyester hexylsubstituted poly(lactic acid) (hexPLA). Additionally, Möller's inventions detail processes for the production of these formulations and their medical uses, highlighting his expertise in advanced pharmaceutical engineering.
Career Highlights
Michael Möller has built his career through significant experiences in various esteemed organizations. Notable companies where he has contributed his expertise include Esbatech, Alcon Biomedical Research Unit LLC, and Sucampo AG. Through these roles, Möller has fostered innovations that bridge the gap between research and practical medical applications.
Collaborations
Over the years, Möller has worked alongside prominent colleagues, including Robert Gurny and Lutz Asmus. These collaborations have undoubtedly enriched his work, leading to the successful development of groundbreaking formulations that enhance patient care.
Conclusion
Michael Möller's inventive spirit and dedication to advancing pharmaceutical science have earned him a distinguished place in the world of patents. His work continues to influence the field, marking him as a key contributor to innovations in drug administration methods. The future holds great promise for his ongoing research and potential inventions that may further improve therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile